Treatment of keloids using injections
Vitamin D in Keloids
This study is testing if injections can help reduce keloids in adults aged 18 to 60.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06729840 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of intralesional injections for treating keloids in patients aged 18 to 60. A total of 45 participants will be divided into three groups, with follow-up assessments conducted before each injection session and three months after the final session. Evaluations will include photographic assessments, scoring, and dermoscopy to measure treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 60 with keloids.
Not a fit: Patients who are pregnant, lactating, or have other skin diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the size and appearance of keloids, improving patients' quality of life.
How similar studies have performed: Previous studies have shown promising results with intralesional treatments for keloids, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Both sex aged 18-60 having keloid \- Exclusion Criteria: * pregnancy , lactation Skin disease
Where this trial is running
Sohag
- Sohag university hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: sama alaa, resident doctor
- Email: samaalaa.867@gmail.com
- Phone: 01027748791
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.